Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Tongue Neoplasms 1Stomatitis 1Radiation Injuries 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Mediastinal Neoplasms 1Laryngeal Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Adenoma, Islet Cell 1

Interventions

Cisplatin 9Cetuximab 9Radiotherapy, Intensity-Modulated 7Everolimus 4Docetaxel 3Carboplatin 3Biopsy 3130-nm albumin-bound paclitaxel 3Ultrasonography 2Taxes 2Radiotherapy 2Radiation 2Photochemotherapy 2Paclitaxel 2Microarray Analysis 2Immunohistochemistry 2Gene Expression Profiling 2Fluorouracil 2Erlotinib Hydrochloride 2Cryosurgery 2Albumin-Bound Paclitaxel 21-phenyl-3,3-dimethyltriazene 2temoporfin 1talactoferrin alfa 1sargramostim 1pimonidazole 1pembrolizumab 1Zinc Oxide 1X-Rays 1Vaccinium myrtillus extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Tongue Neoplasms × Salts × Clear all
NCT00293462 2021-07-30

GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

University of California, San Francisco

Phase 3 Completed
91 enrolled 16 charts
CNSHead & Neck

Head and Neck Neoplasms, Radiation Injuries, Stomatitis, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡